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Nasopharyngeal colonization with Methicillin-resistant Staphylococcus aureus (MRSA) is common in critically ill
patients, but its effect on patient prognosis is not fully elucidated. A retrospective cohort study was carried out
enrolling 122 patients from an intensive care unit who were screened weekly for nasopharyngeal colonization
with MRSA. The outcomes of interest were: general mortality and mortality by infection. Several exposure
variables (severity of illness, procedures, intercurrences and MRSA nasopharyngeal colonization) were analyzed
through univariate and multivariable models. Factors significantly associated with mortality in general or due to
infection were: APACHE II and lung disease. The performance of surgery predicted favorable outcomes. MRSA
colonization did not predict mortality in general (OR=1.02; 95%CI=0.35-3.00; p=0.97) or by infectious causes
(OR=0.96; 95%CI=0.33-2.89; p=0.96). The results suggest that, in the absence of severity of illness factors,
colonization with MRSA is not associated with unfavorable outcomes.
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COLONIZACIÓN NASAL POR EL STAPHYLOCOCCUS AUREUS RESISTENTE A LA
METICILINA Y MORTALIDAD EN PACIENTES DE UNA UNIDAD DE TERAPIA INTENSIVA
La colonización nasofaríngea por el Staphylococcus aureus resistente a la meticilina (Methicillin-resistant S.aureus
- MRSA) es común en pacientes críticamente enfermos, pero su efecto sobre el pronóstico no está completamente
esclarecido. Fue realizado un estudio de Cohorte retrospectivo con 122 pacientes de una Unidad de Terapia
Intensiva que realiza semanalmente exámenes para constatar la colonización nasofaríngea por MRSA. Lo
encontrado de interés fue: mortalidad general y mortalidad por causas infecciosas. Diversas variables de
exposición (gravedad, procedimientos ocurrencias y colonización nasofaríngea por MRSA) fueran analizadas
en modelos univariados y multivariados. Los factores asociados significativamente a la mortalidad en general
o por causas infecciosas fueran: APACHE II y enfermedad pulmonar. La realización de cirugía predijo mejor el
pronóstico. La colonización por MRSA no predijo la mortalidad en general (OR=1.02; IC95%=0.35-3.00; p=0.97)
o por causas infecciosas (OR=0.96; IC95%=0.33-2.89; p=0.96). Los resultados sugieren que, en la ausencia
de factores de gravedad, la colonización por MRSA no se asocia al peor pronóstico.
DESCRIPTORES: Staphylococcus aureus; unidades de terapia intensiva; mortalidad
COLONIZAÇÃO NASAL POR STAPHYLOCOCCUS AUREUS RESISTENTE À METICILINA E
MORTALIDADE EM PACIENTES DE UMA UNIDADE DE TERAPIA INTENSIVA
A colonização de nasofaringe por Staphylococcus aureus, resistente à meticilina (Methicillin-resistant S.aureus
- MRSA), é comum em pacientes criticamente doentes, mas seu significado prognóstico não é inteiramente
conhecido. Realizou-se estudo de coorte retrospectivo com 122 pacientes de uma unidade de terapia intensiva
que realizaram triagem semanal para colonização por MRSA. Os desfechos de interesse foram: mortalidade
geral e mortalidade por infecção. Diversas variáveis de exposição (gravidade, procedimentos, intercorrências
e colonização nasofaríngea por MRSA) foram analisadas em modelos univariados e multivariados. Fatores
significativamente associados à mortalidade geral ou por infecção foram: APACHE II e doença pulmonar. A
colonização por MRSA não foi preditora de mortalidade geral (OR=1,02; IC95%=0,35-3; p=0,97) ou por infecção
(OR=0,96; IC95%=0,33-2,89; p=0,96). Os resultados sugerem que, na ausência de fatores de gravidade, a
colonização por MRSA não caracteriza pior prognóstico.
DESCRITORES: Staphylococcus aureus; unidades de terapia intensiva; mortalidade
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INTRODUCTION
Hospital-acquired infections (HAI) are
among the main adverse occurrences related to
the care of patients in Intensive Care Units (ICUs)(1).
A predominance of multidrug-resistant (MDR)
microorganisms has been shown in the etiology of
these infections(2) in several countries, including
Brazil. MDR microorganisms are defined as those
that are resistant to one or more classes of
antimicrobials routinely used in their treatments(3).
The methicillin-resistant staphylococcus aureus
(MRSA) stands out among them. This bacterium
was first described in Europe in 1961 and was
globally disseminated in fol lowing decades(4).
Strains of MRSA are resistant to all beta-lactam
drugs (penic i l l ins, cephalosporins and
carbapenems) and several  other c lasses of
antimicrobials (clindamycin, quinolones)(5).
Data from the National Nosocomial Infection
Surveillance System (NNIS) in the United States
reveal that MRSA corresponded to 59.5% of S.aureus
strains isolated from ICUs(6). Brazilian data point to a
similar scenario. A report from the Epidemiological
Surveillance Center of the state of Sao Paulo has
identified S.aureus as the second most frequent
bacterium found in blood cultures collected in ICUs,
corresponding to 26.7% of positive exams; among
the isolated strains, 58.8% were MRSA(7).
Nasopharyngeal colonization generally
precedes the emergence of infection by MRSA. In
addition, colonized patients can spread this agent in
ICUs, contributing to increased morbidity and
mortality(8). The identification and isolation of
individuals infected by MRSA, even when these do
not present signs of active infection, contribute to
reduce the circulation of this agent and also its
participation in the HAI etiology. A common practice
used to identify colonized individuals is the
performance of “active surveillance cultures”(9), a
periodic collection of cultures of nasopharyngeal
secretions using swabs.
Although the epidemiological utility of
surveillance cultures has been proven, the impact of
nasal colonization in patients’ prognosis has not been
established(9). This study’s objective was twofold: to
analyze the effect of MRSA colonization on the
prognosis of patients hospitalized in Intensive Care
Units and to identify other predictors of mortality for
the patients of this study.
METHOD
Study site
This study was carried out in the Adults’
Intensive Care Unit (AICU) of the Bauru State Hospital
(BSH). This is a teaching hospital linked to Botucatu
School of Medicine, Sao Paulo State University
(UNESP). The hospital currently has 280 beds in use
and four ICUs. The AICU has 11 beds and cares for
medical and surgical patients.
Study Design
This is a retrospective cohort study, enrolling
122 patients admitted to the AICU between May 2005
and March 2006. These patients were screened for
MRSA through surveillance cultures (nasopharyngeal
swabs) at the time of their admission and weekly during
their hospitalization. Procedures for microbiological
analysis and antimicrobial susceptibility tests followed
standards recommended by the literature(10). Two
outcomes were considered: (1) death and (2) death
caused by or related to infection.
The following variables were studied: (1)
demographic data; (2) comorbidities and severity of
illness at the time of admission; (3) invasive
procedures, devices and use of imunossupressive
medication; (4) HAI diagnosis; (5) MRSA colonization.
These data were evaluated in relation to the overall
chance of dying (Study 1) and to death caused by/
related to infection (Study 2). The severity of patients’
conditions was determined by scores obtained in the
Acute Physiology and Chronic Health Evaluation II
(APACHE II), computed at the time of admission(11).
Definitions of HAI followed guidelines provided by the
Centers for Disease Control and Prevention(12).
Statistical analysis
Data were entered in the EPI INFO v.3.2. (©DC,
USA) and analyzed through the SPSS statistical
software v.15.0 (©SPSS Inc.).
Univariate analysis
Dichotomous variables were analyzed
through the Chi-Square Test or Fischer’s Exact Test,
when appropriate. Age was evaluated by the Student’s
T-Test, while APACHE II scores were evaluated through
the Mann-Whitney Test.
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Multivariable analysis
Variables were included in hierarchical
models of logist ic regression. The order of
introduction was: 1st group – demographic data;
2nd group – comorbidities and severity of illness at
the t ime of admission; 3 rd group – invasive
procedures, use of devices and immunosuppressive
medication; 4th group – HAI diagnosis. A significance
level of 0.05 was required for variables to be kept
in the models. However, because MSRA colonization
was the variable of primary interest in this study,
it was forced into all models, even when it did not
reach the required statistical significance. The limit
used to define significance in the final model was
0.05.
Ethical aspects
This study was approved by the Ethics
Committee for Research with human subjects and is
included in the project: Risk factors for the acquisition
of isolated multiresistant Staphylococcus aureus and
Pseudomonas aeruginosa in patients at the Bauru
State Hospital.
RESULTS
MRSA colonization was detected through
surveillance cultures in thirty of the studied patients.
Mortality in the followed cohort was high: 94 deaths
(77%), 67 of which were related to or caused by
hospital-acquired infection.
In Study 1, which investigated predictors for
general mortality, univariate analysis (Table 1)
identified age, lung disease, APACHE II, mechanical
ventilation, the presence of nasogastric tubes and
diagnosis of sepsis as risk factors for death. Surgeries
and drains, on the other hand, were associated with
a better prognosis. In the multivariable analysis (Table
3), only APACHE II and lung disease were implicated
in a higher death risk. The practice of surgery
presented a negative association with mortality. MSRA
colonization was not associated with a worse outcome
(OR=0.76; CI 95%=0.30-1,97; p=0,58).
Table 1 – Mortality risk factors in patients in the Intensive Care Unit at the Bauru State Hospital (univariate
analysis)
Data in number and percentage, except when indicated
*Statistically significant variables
OR=Odds Ratio. CNS = Central Nervous System. APACHE=Acute Physiology and Chronic Health Evaluation (severity scoring system for patients in ICU).
MRSA= Methicillin-resistant Staphylococcus aureus
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Study 2 (predictors for mortality by infection)
identified the same risk factors found in the univariate
analysis carried out in Study 1 (Table 2). In the stage
of multivariable analysis, APACHE II and lung disease
were predictors of a worse prognosis (Table 3). Once
again, MSRA colonization was not associated with a
higher risk of death caused by or related to infection
(OR=0.96; CI95%=0.33-2.89; p=0.96).
Table 2 – Mortality risk factors related to or caused by hospital-acquired infection in patients in the Intensive
Care Unit at the Bauru State Hospital (univariate analysis)
*Statistically significant variables
OR=odds ratio. CNS = Central Nervous System. APACHE=Acute Physiology and Chronic Health Evaluation (severity scoring system for patients in ICU)
MRSA= Methicillin-resistant Staphylococcus aureus
Table 3 – Multivariable analysis of risk factors related
to general mortality and mortality related to or caused
by hospital-acquired infection in patients in the
Intensive Care Unit at the Bauru State Hospital
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OR=odds ratio. APACHE=Acute Physiology and Chronic Health Evaluation
(severity scoring system for patients in ICU). MRSA= Methicillin-resistant
Staphylococcus aureus
DISCUSSION
Infection control practices should be seen as
an important part of a larger context: the promotion
of quality and safe care to patients(13). That is why a
critical evaluation of risks related to healthcare is
essential and applies to the control of MDR
microorganisms. This study aims to contribute to a
better understanding of the risks posed by the
acquisition of MRSA in critical patients.
Some recent studies evaluated mortality due
to MSRA in hospitalized patients. The majority involved
patients with blood cultures positive for MRSA
(bacteremia). One of these studies carried out in a
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Brazilian teaching hospital compared mortality in
patients with cultures positive for MSRA and for
methicillin-susceptible S.aureus (MSSA). The authors
concluded that the risk was higher for patients affected
by MRSA(14). One study from the United States, on
the other hand, compared similar groups, carefully
matching cases according to the severity of illness(15)
and their results did not find differences in mortality
between MRSA and MSSA patients. Patients with
MRSA, though, were hospitalized for longer periods
and incurred higher costs for the hospital. Other studies
addressing patients with bacteremia obtained
conflicting results(16-17).
Studies that follow cohorts of patients
colonized by MRSA are rarer. The follow up of
transplanted patients and/or patients awaiting for
hepatic transplantation revealed that nasal carriage
increased the risk of infection by 15 fold but had no
impact on mortality(18). In another study, authors
followed individuals chronically infected by MRSA(19)
and, of the 281 persistent carriers, 96 presented
infections and 14 died.
In the casuistic of this study, asymptomatic
carriage of MRSA did not increase the risk of general
mortality nor of mortality caused by infection. Instead,
the usual mortality predictors in patients in ICUs were
identified. The APACHE II is a scoring system that
has the precise function of predicting death risk.
Therefore, its statistical significance is not surprising.
The presence of lung disease increases the need for
ventilatory support and the risk of hospital-acquired
pneumonia. Surgical patients, on the other hand, are
known to be the group with the best prognosis(11).
Although these findings are interesting, they
should be interpreted with caution. The fact that MRSA
colonization by itself does not determine death does
not mean that infections by this agent are associated
with a good prognosis. One should take into account
that mortality in the studied cohort was very high
(77%). In other words, MRSA colonization did not
increase the risk of death in a group of severely ill
patients. What would have been the results if we had
studied individuals whose primary diseases had a
better prognosis? Further research is needed to
answer this question.
Another question arises. Will the results of
this study be used as a rationale against the need for
active surveillance cultures? It is a fact that the
collection of these cultures increases laboratorial costs
and the workload of professionals from infection control
committees(8-9). However, we believe that a conclusive
answer for the real need for surveillance cultures
requires clarification of other factors. Among them,
the impact of MRSA colonization on the incidence of
infections, patients’ length of stay at the hospital and
hospital costs. This is an open field for research.
We know that MRSA is an important agent of
HAIs in ICUs. A rigid implementation of protocols to
prevent HAIs, isolation precautions and hand hygiene
is recommended for its control. Intervention studies
have shown that increased adherence to these
measures reduces HAI and mortality rates(20). This is
a challenge for health professionals, on whose hands
lay (literally) the responsibility for controlling infections.
We conclude that MRSA colonization in the
studied population was not associated with higher
mortality rates. Other studies – focusing on morbidity
indicators and hospital costs – are necessary to better
assess the impact of this agent in patients admitted
to ICUs.
REFERENCES
1. Forster AJ, Kyeremanteng K, Hooper J, Shojania KG, van
Walraven C. The impact of adverse events in the intensive
care unit on hospital mortality and length of stay. BMC Health
Serv Res 2008 December; 8(12):259-67.
2. Rosenthal VD, Maki DG, Salomao R, Moreno CA, Mehta Y,
Higuera F, Cuellar LE, Arikan OA, Abouqal R, Leblebicioglu
H; International Nosocomial Infection Control Consortium.
Device-associated nosocomial infections in 55 intensive care
units of 8 developing countries. Ann Intern Med 2006;
145(8):582-91.
3. Siegel JD, Rhinehart E, Jackson M, Chiarello L, Healthcare
Infection Control Practices Advisory Committee.
Management of multidrug-resistant organisms in health care
settings, 2006. Am J Infect Control 2007; 35(10 Suppl
2):S165-93.
4. Kreiswirth B, Kornblum J, Arbeit RD, Eisner W, Maslow JN,
McGeer A, Low DE, Novick RP. Evidence for a clonal origin of
methicillin resistance in Staphylococcus aureus. Science
1993; 259(5092):227-30.
5. Chambers HF. The changing epidemiology of
Staphylococcus aureus? Emerg Infect Dis 2001 March-April;
7(2):178-82.
6. National Nosocomial Infections Surveillance. National
Nosocomial Infections Surveillance (NNIS) System Report,
data summary from January 1992 through June 2004, issued
October 2004. Am J Infect Control 2004 December;
32(8):470-85.
7. Assis DB, Madalosso G, Ferreira AS, Yassuda YY, Geremias
AL. Análise dos dados de infecção hospitalar do Estado de
São Paulo – Ano 2007. Boletim Epidemiológico Paulista
Rev Latino-am Enfermagem 2009 setembro-outubro; 17(5):677-82
www.eerp.usp.br/rlae
Nasopharyngeal colonization with methicillin-resistant staphylococcus…
Fortaleza CR, Melo EC, Fortaleza CMCB.
682
(BEPA) 2008; 5(53):12-23.
8. Jarvis WR. The epidemiology of colonization. Infect Control
Hosp Epidemiol 1996; 17(1):47-52.
9. McGinigle KL, Gourlay ML, Buchanan IB. The use of active
surveillance cultures in adult intensive care units to reduce
methicill in-resistant Staphylococcus aureus-related
morbidity, mortality, and costs: a systematic review. Clin Infect
Dis 2008; 46(11):1717-25.
10. National Committee on Clinical Laboratory Standards.
Performance standards for Antimicrobial Disk Susceptibility
Tests; Approved Standard—Eighth Edition. NCCLS document
M2-A8. Pennsylvania (EUA): NCCLS; 2003.
11. Knaus WA, Draper EA, Wagner DP, Zimmerman JE.
APACHE II: a severity of disease classification system. Crit
Care Med 1985 October; 13(10):818-29.
12. Horan TC, Andrus M, Dudeck MA. CDC/NHSN
surveillance definition of health care–associated infection
and criteria for specific types of infections in the acute care
setting. Am J Infect Control 2008 June; 36(5):309-32.
13. Lacerda RA. Produção científica infecção hospitalar e a
contribuição da enfermagem: ontem, hoje e perspectivas. Rev
Latino-am Enfermagem 2002; 10(1):55-63.
14. Conterno LO, Wey SB, Castelo A. Risk factors for mortality
in Staphylococcus aureus bacteremia. Infec. Control Hosp.
Epidemiol 1998; 19(1):32-7.
15. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW,
Carmeli Y. The impact of methicill in resistance in
Staphylococcus aureus bacteremia on patient outcomes:
mortality, length of stay, and hospital charges. Infect Control
Hosp Epidemiol 2005; 26(2):166-74.
16. Laupland KB, Ross T, Gregson DB. Staphylococcus aureus
bloodstream infections: risk factors, outcomes, and the
influence of Methicillin resistance in Calgary, Canada, 2000-
2006. J Infect Dis 2008 August; 198(3):336-43.
17. Wang FD, Chen YY, Chen TL, Liu CY. Risk factors and
mortality in patients with nosocomial Staphylococcus aureus
bacteremia. Am J Infect Control 2008 March; 32(2):118-22.
18. Russell DL, Flood A, Zaroda TE, Acosta C, Riley MM,
Busuttil RW et al. Outcomes of Colonization with MRSA and
VRE Among Liver Transplant Candidates and Recipients. Am
J Transplant. 2008; 8(8):1737-43.
19. Datta R, Huang SS. Risk of infection and death due to
methicillin-resistant Staphylococcus aureus in long-term
carriers. Clin Infect Dis 2008 August; 47(2):176-81.
20. Moreira M, Freitas MR, Martins ST, Castelo A, Medeiros
EA. Efficacy of a program of prevention and control for
Methicillin-Resistant Staphylococcus aureus infections in an
Intensive-Care Unit. Braz J Infect Dis 2007; 11(1):57-62.
Recebido em: 23.7.2008
Aprovado em: 3.8.2009
Nasopharyngeal colonization with methicillin-resistant staphylococcus…
Fortaleza CR, Melo EC, Fortaleza CMCB.
Rev Latino-am Enfermagem 2009 setembro-outubro; 17(5):677-82
www.eerp.usp.br/rlae
